General form of registration statement for all companies including face-amount certificate companies

14. Stock-Based Compensation (Tables)

v3.10.0.1
14. Stock-Based Compensation (Tables)
6 Months Ended 12 Months Ended
Sep. 30, 2018
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]    
Weighted-average assumptions of fair value of employee stock options  
    Year Ended March 31,  
    2018     2017  
Fair value of the Company’s common stock on date of grant   $ 6.78     $ 4.87  
Expected term     6.42 yrs       5.73 yrs  
Risk-free interest rate     2.04%       1.91%  
Dividend yield     0.00%       0.00%  
Volatility     120.8%       126.0%  
Fair value of options granted   $ 5.97     $ 4.12  
Employee stock-based compensation expense
    Three Months     Six Months  
    Ended     Ended  
    September 30,     September 30,  
    2018     2017     2018     2017  
Cost of service revenue   $ 30,000     $ 49,000     $ 65,000     $ 93,000  
Research and development     29,000       45,000       61,000       90,000  
Selling, general and administrative     467,000       333,000       747,000       682,000  
Total stock-based compensation   $ 526,000     $ 427,000     $ 873,000     $ 865,000  
    Year Ended March 31,  
    2018     2017  
Cost of revenues   $ 169,000     $ 248,000  
Research and development     159,000       245,000  
Selling, general and administrative     2,082,000       1,652,000  
Total stock-based compensation   $ 2,410,000     $ 2,145,000  
Plan summary  
          Unvested        
Plan   Stock Options     Restricted Stock     Total  
2006 Plan     163,000             163,000  
2011 Plan     1,000,000       9,000       1,009,000  
2016 Plan     230,000       23,000       253,000  
      1,393,000       32,000       1,425,000  
Stock-based awards available for grant as of March 31, 2018                     1,455,000  
Schedule of option activity
   

Number of

Shares

   

Weighted-

Average

Exercise Price

   

Weighted-

Average

Contractual Term

   

Aggregate

Intrinsic

Value

 
Outstanding at April 1, 2018     1,393,000     $ 12.70                  
Options granted     159,000       2.64                  
Options forfeited     (33,000 )     6.70                  
Options expired     (3,000 )     18.44                  
Outstanding at September 30, 2018     1,516,000     $ 11.76       7.02     $  
Exercisable at September 30, 2018     1,109,000     $ 13.75       6.48     $  
    Number of
Shares
    Weighted-
Average
Exercise Price
    Weighted-
Average
Contractual Term
    Aggregate
Intrinsic
Value
 
Outstanding at April 1, 2017     899,000     $ 17.87                  
Options granted     554,000       6.78                  
Options exercised     (1,000 )     5.27                  
Options forfeited     (51,000 )     6.78                  
Options expired     (8,000 )     222.37                  
Outstanding at March 31, 2018     1,393,000     $ 12.70       7.45     $  
Exercisable at March 31, 2018     796,000     $ 17.32       6.35     $  
Schedule of unvested restricted stock activity
   

Number of

Shares

   

Weighted

Average Award

Date Fair Value

per Share

 
Unvested restricted stock awards outstanding at April 1, 2018     32,000     $ 6.46  
Restricted stock awards granted     28,000       1.90  
Restricted stock awards forfeited     (4,000 )     6.97  
Restricted stock awards vested     (16,000 )     5.50  
Unvested restricted stock awards outstanding at September 30, 2018     40,000     $ 3.71  
   

Number of

Shares

   

Weighted

Average Award

Date Fair Value

per Share

 
Unvested restricted stock awards outstanding at April 1, 2017     34,000     $ 7.27  
Restricted stock awards granted     199,000       5.58  
Restricted stock awards vested     (201,000 )     5.72  
Restricted stock awards forfeited            
Unvested restricted stock awards outstanding at March 31, 2018     32,000     $ 6.46